[HTML][HTML] Improving cancer care for patients with CKD: the need for changes in clinical trials

B Sprangers, MA Perazella, SM Lichtman… - Kidney International …, 2022 - Elsevier
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices
along with potentially serious adverse toxicities. Many cancer drugs are at least partially …

[引用][C] Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

B Sprangers, MA Perazella, SM Lichtman… - Kidney International …, 2022 - elibrary.ru

Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

B Sprangers, MA Perazella… - Kidney …, 2022 - pubmed.ncbi.nlm.nih.gov
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices
along with potentially serious adverse toxicities. Many cancer drugs are at least partially …

[HTML][HTML] Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

B Sprangers, MA Perazella, SM Lichtman… - Kidney International …, 2022 - ncbi.nlm.nih.gov
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices
along with potentially serious adverse toxicities. Many cancer drugs are at least partially …

Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials.

B Sprangers, MA Perazella, SM Lichtman… - Kidney International …, 2022 - europepmc.org
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices
along with potentially serious adverse toxicities. Many cancer drugs are at least partially …

[HTML][HTML] Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials

B Sprangers, MA Perazella, SM Lichtman… - Kidney International …, 2022 - kireports.org
Chemotherapeutic agents used to treat cancer generally have narrow therapeutic indices
along with potentially serious adverse toxicities. Many cancer drugs are at least partially …